Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Wall Street
Price Targets
Price Targets Summary
Hunan Fangsheng Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Hunan Fangsheng Pharmaceutical Co Ltd is 10.52 CNY with a low forecast of 10.41 CNY and a high forecast of 10.83 CNY.
Revenue
Forecast
Revenue Estimate
Hunan Fangsheng Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's revenue is 17%. The projected CAGR for the next 2 years is 19%.
Operating Income
Forecast
Operating Income Estimate
Hunan Fangsheng Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 2 years is 35%.
Net Income
Forecast
Net Income Estimate
Hunan Fangsheng Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's net income is 9%. The projected CAGR for the next 2 years is 27%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hunan Fangsheng Pharmaceutical Co Ltd's stock price target?
Price Target
10.52
CNY
According to Wall Street analysts, the average 1-year price target for Hunan Fangsheng Pharmaceutical Co Ltd is 10.52 CNY with a low forecast of 10.41 CNY and a high forecast of 10.83 CNY.
What is Hunan Fangsheng Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
19%
For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's revenue is 17%. The projected CAGR for the next 2 years is 19%.
What is Hunan Fangsheng Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
35%
For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 2 years is 35%.
What is Hunan Fangsheng Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
27%
For the last 8 years the compound annual growth rate for Hunan Fangsheng Pharmaceutical Co Ltd's net income is 9%. The projected CAGR for the next 2 years is 27%.